News
Huang Lab to Present Preclinical PH102 Data at the 2024 San Antonio Liver Cancer Symposium
September 30, 2024
SAN ANTONIO, Texas — The Huang Lab at the Mays Cancer Center at UT Health San Antonio will present new preclinical data on PH102 at the 2024 San Antonio Liver Cancer Symposium. Dr. Gang Huang will deliver a seminar talk. Vincent Pham, Cancer Biology PhD Candidate, will present a poster highlighting complementary results. PH102 is […]
Huang Lab Publishes Review on Cytokine Storm Syndromes in Frontiers in Immunology
September 9, 2024
SAN ANTONIO, Texas — The Huang Lab announces the publication of a review titled “Into the storm: the imbalance in the yin‑yang immune response as the commonality of cytokine storm syndromes” in Frontiers in Immunology. The article appears in the Inflammation section, Volume 15. Frontiers Authors include Amy Armstrong, Yuting Tang, Neelam Mukherjee, Nu Zhang, […]
Huang Lab Spins Off PH102 and Solid‑Tumor Cell Therapy Programs into Powerhouse Therapeutics Inc
August 4, 2024
SAN ANTONIO, Texas — The Huang Lab at the Mays Cancer Center at UT Health San Antonio announced the formation of Powerhouse Therapeutics Inc, a biotechnology startup created to advance PH102 and a subset of the lab’s solid‑tumor cell therapy portfolio toward the clinic. The new company will focus on translational development, manufacturing readiness, and […]